LRRK2 and Parkinson disease: With HDX-MS and GaMD, we are beginning to achieve a deeper molecular understanding of these critical domain:domain interfaces as well as loop dynamics, which all contribute to the allosteric regulation of LRRK2 and are perturbed by mutations that make LRRK2 a risk factor for PD.